| Literature DB >> 25640402 |
Patrick A Carroll1, Daniel Diolaiti1, Lisa McFerrin1, Haiwei Gu2, Danijel Djukovic2, Jianhai Du3, Pei Feng Cheng1, Sarah Anderson1, Michelle Ulrich1, James B Hurley4, Daniel Raftery5, Donald E Ayer6, Robert N Eisenman7.
Abstract
Deregulated Myc transcriptionally reprograms cell metabolism to promote neoplasia. Here we show that oncogenic Myc requires the Myc superfamily member MondoA, a nutrient-sensing transcription factor, for tumorigenesis. Knockdown of MondoA, or its dimerization partner Mlx, blocks Myc-induced reprogramming of multiple metabolic pathways, resulting in apoptosis. Identification and knockdown of genes coregulated by Myc and MondoA have allowed us to define metabolic functions required by deregulated Myc and demonstrate a critical role for lipid biosynthesis in survival of Myc-driven cancer. Furthermore, overexpression of a subset of Myc and MondoA coregulated genes correlates with poor outcome of patients with diverse cancers. Coregulation of cancer metabolism by Myc and MondoA provides the potential for therapeutics aimed at inhibiting MondoA and its target genes.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25640402 PMCID: PMC4326605 DOI: 10.1016/j.ccell.2014.11.024
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743